НовостиBenzingaCanaccord Genuity Maintains Buy on Palvella Therapeutics, Raises Price Target to $243 Canaccord Genuity Maintains Buy on Palvella Therapeutics, Raises Price Target to $243 Benzinga 2026.11.09 18:13 (GMT+0) Открыть на Benzinga Другие новости